1. Home >
  2. M&A >
  3. Merger >
  4. China >
  5. Caidya Acquires dMed

M&A Deal Summary

Caidya Acquires dMed

On April 28, 2021, Caidya acquired life science company dMed

Acquisition Highlights
  • This is Caidya’s 7th transaction in the Life Science sector.
  • This is Caidya’s 1st transaction in China.

M&A Deal Summary
Date 2021-04-28
Target dMed
Sector Life Science
Buyer(s) Caidya
Deal Type Merger

Target

dMed

Shanghai, China
dMed is a clinical contract research organization serving and global biopharmaceutical and medical device companies. dMed was founded in 2016 and is based in Shanghai, China.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Caidya

Morrisville, North Carolina, United States
Category Company
Founded 2003
Sector Life Science
DESCRIPTION

Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya is a proprietary clinical technology to ensure trial transparency and data-driven decision-making. Caidya was founded in 2003 and is based in Morrisville, North Carolina.

DEAL STATS #
Overall 7 of 7
Sector: Life Science M&A 7 of 7
Type: Merger M&A Deals 1 of 1
Country: China M&A 1 of 1
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-13 Accovion

Eschborn, Germany

Accovion GmbH is a provider of clinical research services to the pharmaceutical, biotechnology and medical device industries.

Buy -
Mergr

Solution for

Product

Company

Legal